Atul R. Mahableshwarkar, MD
- 3Articles
- 23.7KReads
- 2012–2015Active
- 8Collaborators
- 267Citations
About
Atul R. Mahableshwarkar, MD, has contributed to research on major depressive disorder (MDD), focusing on the efficacy and safety of vortioxetine and other pharmacological treatments. Between 2012 and 2015, Mahableshwarkar authored multiple randomized, double-blind, placebo-controlled clinical trials examining various doses of these medications in adults with MDD. Collaborators frequently included Madhukar H. Trivedi, Michael Serenko, Paula L. Jacobsen, Yinzhong Chen, and Michael E. Thase.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
